Skip to main content

Bayer Buys Sample-Prep System From Hamilton to Develop IVD Platform

NEW YORK (GenomeWeb News) - Bayer Healthcare today said it will buy a customized Microlab STARlet sample-preparation system from Hamilton Company as part of its plan to develop a new platform for performing molecular diagnostics.
 
The two companies will work together to customize the platform to meet the requirements of Bayer’s quantitative PCR technology.
 
Financial terms of the deal were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.